[go: up one dir, main page]

GB0426142D0 - Formulation - Google Patents

Formulation

Info

Publication number
GB0426142D0
GB0426142D0 GB0426142A GB0426142A GB0426142D0 GB 0426142 D0 GB0426142 D0 GB 0426142D0 GB 0426142 A GB0426142 A GB 0426142A GB 0426142 A GB0426142 A GB 0426142A GB 0426142 D0 GB0426142 D0 GB 0426142D0
Authority
GB
United Kingdom
Prior art keywords
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0426142A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UCL Business Ltd
Original Assignee
UCL Biomedica PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UCL Biomedica PLC filed Critical UCL Biomedica PLC
Priority to GB0426142A priority Critical patent/GB0426142D0/en
Publication of GB0426142D0 publication Critical patent/GB0426142D0/en
Priority to ES10014283.5T priority patent/ES2537974T3/en
Priority to CN2005800469901A priority patent/CN101102816B/en
Priority to AT05808837T priority patent/ATE457187T1/en
Priority to AU2005308622A priority patent/AU2005308622B2/en
Priority to ES05808837T priority patent/ES2341120T3/en
Priority to DK05808837.8T priority patent/DK1824563T3/en
Priority to SI200531970T priority patent/SI2319581T1/en
Priority to US11/720,268 priority patent/US8389576B2/en
Priority to EP09013613.6A priority patent/EP2153870B1/en
Priority to MX2007006171A priority patent/MX2007006171A/en
Priority to JP2007542118A priority patent/JP5116479B2/en
Priority to CN201110304561.7A priority patent/CN102512408B/en
Priority to PL09013613T priority patent/PL2153870T3/en
Priority to KR1020077014477A priority patent/KR101380446B1/en
Priority to ES09013613.6T priority patent/ES2448549T3/en
Priority to PT90136136T priority patent/PT2153870E/en
Priority to EA200701146A priority patent/EA011716B1/en
Priority to SG200907712-4A priority patent/SG158073A1/en
Priority to EP10014283.5A priority patent/EP2319581B1/en
Priority to EP05808837A priority patent/EP1824563B1/en
Priority to DK10014283.5T priority patent/DK2319581T3/en
Priority to PCT/GB2005/004539 priority patent/WO2006056794A1/en
Priority to EA200900105A priority patent/EA018007B1/en
Priority to DK09013613.6T priority patent/DK2153870T3/en
Priority to PL05808837T priority patent/PL1824563T3/en
Priority to PT100142835T priority patent/PT2319581E/en
Priority to DE602005019319T priority patent/DE602005019319D1/en
Priority to CA2589261A priority patent/CA2589261C/en
Priority to SI200531834T priority patent/SI2153870T1/en
Priority to PL10014283T priority patent/PL2319581T3/en
Priority to PT05808837T priority patent/PT1824563E/en
Priority to SI200530993T priority patent/SI1824563T1/en
Priority to NZ555870A priority patent/NZ555870A/en
Priority to IL183401A priority patent/IL183401A/en
Priority to NO20073254A priority patent/NO342198B1/en
Priority to CY20101100397T priority patent/CY1112259T1/en
Priority to HK10107783.4A priority patent/HK1141471B/en
Priority to US13/495,966 priority patent/US9566257B2/en
Priority to JP2012157179A priority patent/JP5612030B2/en
Priority to CY20141100215T priority patent/CY1114979T1/en
Priority to CY20151100464T priority patent/CY1116314T1/en
Priority to NO20161808A priority patent/NO341491B1/en
Priority to US15/430,233 priority patent/US10610506B2/en
Ceased legal-status Critical Current

Links

GB0426142A 2004-11-26 2004-11-26 Formulation Ceased GB0426142D0 (en)

Priority Applications (44)

Application Number Priority Date Filing Date Title
GB0426142A GB0426142D0 (en) 2004-11-26 2004-11-26 Formulation
NZ555870A NZ555870A (en) 2004-11-26 2005-11-28 Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
EP05808837A EP1824563B1 (en) 2004-11-26 2005-11-28 Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
CN2005800469901A CN101102816B (en) 2004-11-26 2005-11-28 Compositions containing ornithine and phenylacetate or phenylbutyrate for the treatment of hepatic encephalopathy
AT05808837T ATE457187T1 (en) 2004-11-26 2005-11-28 COMPOSITIONS CONTAINING ORNITHINE AND PHENYL ACETATE OR PHENYLBUTYRATE FOR THE TREATMENT OF HEPATIC ENCEPHALOPATHY
AU2005308622A AU2005308622B2 (en) 2004-11-26 2005-11-28 Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
ES05808837T ES2341120T3 (en) 2004-11-26 2005-11-28 COMPOSITIONS THAT INCLUDE ORNITINE AND PHENYLACETATE OR PHENYLBUTIRATE TO TREAT HEPATIC ENCEPHALOPATHY.
DK05808837.8T DK1824563T3 (en) 2004-11-26 2005-11-28 Compositions comprising ornithine and phenylacetate or phenylbutyrate for the treatment of hepatic encephalopathy
SI200531970T SI2319581T1 (en) 2004-11-26 2005-11-28 Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
US11/720,268 US8389576B2 (en) 2004-11-26 2005-11-28 Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
EP09013613.6A EP2153870B1 (en) 2004-11-26 2005-11-28 Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
MX2007006171A MX2007006171A (en) 2004-11-26 2005-11-28 Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy.
JP2007542118A JP5116479B2 (en) 2004-11-26 2005-11-28 A composition for treating hepatic encephalopathy comprising ornithine and phenylacetate or phenylbutyrate
CN201110304561.7A CN102512408B (en) 2004-11-26 2005-11-28 Be used for the treatment of the compositions containing ornithine and phenylacetic acid or phenylbutyric acid of hepatic encephalopathy
PL09013613T PL2153870T3 (en) 2004-11-26 2005-11-28 Compositions containing ornithine and phenylacetate or phenylbutyrate for the treatment of hepatic encephalopathy
KR1020077014477A KR101380446B1 (en) 2004-11-26 2005-11-28 Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
ES09013613.6T ES2448549T3 (en) 2004-11-26 2005-11-28 Compositions comprising ornithine and phenylacetate or phenylbutyrate to treat hepatic encephalopathy
PT90136136T PT2153870E (en) 2004-11-26 2005-11-28 COMPOSITIONS UNDER ORNITINE AND PHENYL ACETATE OR PHENYLBUTIRATE FOR TREATMENT OF HEPATIC ENCEPHALOPATHY
EA200701146A EA011716B1 (en) 2004-11-26 2005-11-28 COMPOSITION CONTAINING ORNITIN AND PHENYL ACETATE OR PHENYBUTIRATE FOR THE TREATMENT OF HEPATIC ENCEPHALOPATHY
SG200907712-4A SG158073A1 (en) 2004-11-26 2005-11-28 Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
EP10014283.5A EP2319581B1 (en) 2004-11-26 2005-11-28 Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
ES10014283.5T ES2537974T3 (en) 2004-11-26 2005-11-28 Compositions comprising ornithine and phenylacetate or phenylbutyrate for the treatment of hepatic encephalopathy
PCT/GB2005/004539 WO2006056794A1 (en) 2004-11-26 2005-11-28 Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
EA200900105A EA018007B1 (en) 2004-11-26 2005-11-28 COMPOSITION CONTAINING ORNITIN AND PHENYL ACETATE OR PHENYBUTIRATE FOR THE TREATMENT OF HEPATIC ENCEPHALOPATHY
DK10014283.5T DK2319581T3 (en) 2004-11-26 2005-11-28 Compositions comprising ornithine and phenylacetate phenylbutyrate OR TREATMENT hepatic encephalopathy
DK09013613.6T DK2153870T3 (en) 2004-11-26 2005-11-28 COMPOSITIONS COMPRISING ornithine and phenylacetate phenylbutyrate OR TREATMENT hepatic encephalopathy
PL05808837T PL1824563T3 (en) 2004-11-26 2005-11-28 Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
PT100142835T PT2319581E (en) 2004-11-26 2005-11-28 COMPOSITIONS UNDER ORNITINE AND PHENYL ACETATE OR PHENYLBUTIRATE FOR TREATMENT OF HEPATIC ENCEPHALOPATHY
DE602005019319T DE602005019319D1 (en) 2004-11-26 2005-11-28 COMPOSITIONS WITH ORNITHIN AND PHENYL ACETATE OR PHENYLBUTYRATE FOR THE TREATMENT OF HEPATIC ENZEPHALOPATHY
CA2589261A CA2589261C (en) 2004-11-26 2005-11-28 Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
SI200531834T SI2153870T1 (en) 2004-11-26 2005-11-28 Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
PL10014283T PL2319581T3 (en) 2004-11-26 2005-11-28 Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
PT05808837T PT1824563E (en) 2004-11-26 2005-11-28 COMPOSITIONS UNDER ORNITINE AND PHENYL ACETATE OR PHENYLBUTIRATE FOR TREATMENT OF HEPATIC ENCEPHALOPATHY
SI200530993T SI1824563T1 (en) 2004-11-26 2005-11-28 Compositions comprising ornithine and phenylacetate or phenylbutyrate for the treatment of hepatic encephalopathy
IL183401A IL183401A (en) 2004-11-26 2007-05-24 Use of ornithine and ornithine with at least one phenyl acetate and phenyl butyrate in the manufacture of a medicinal product, products and compositions containing them for use in the prevention or treatment of liver breakdown and encephalopathy of the liver
NO20073254A NO342198B1 (en) 2004-11-26 2007-06-25 Compositions comprising ornithine and phenylacetate or phenylbutyrate to treat hepatic encephalopathy
CY20101100397T CY1112259T1 (en) 2004-11-26 2010-05-07 COMPOSITIONS THAT INCLUDE ORNITHINE AND PHENYLUXIC OR PHENYLUBUTURYSIS FOR TREATMENT OF US HEALTHCARE
HK10107783.4A HK1141471B (en) 2004-11-26 2010-08-16 Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
US13/495,966 US9566257B2 (en) 2004-11-26 2012-06-13 Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy
JP2012157179A JP5612030B2 (en) 2004-11-26 2012-07-13 A composition for treating hepatic encephalopathy comprising ornithine and phenylacetate or phenylbutyrate
CY20141100215T CY1114979T1 (en) 2004-11-26 2014-03-18 COMPOSITIONS THAT INCLUDE ORNITHINE AND PHENYLUXIC OR PHENYLUBUTURIC FOR USE HEALTHCARE HEALTH
CY20151100464T CY1116314T1 (en) 2004-11-26 2015-05-25 COMPOSITIONS CONTAINING ORNITHINE AND ACETIC PAIN OR BUTTERY PAIN FOR THE Treatment of US Cerebral Palsy
NO20161808A NO341491B1 (en) 2004-11-26 2016-11-16 Compositions comprising ornithine and phenylacetate or phenylbutyrate to treat hepatic encephalopathy
US15/430,233 US10610506B2 (en) 2004-11-26 2017-02-10 Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0426142A GB0426142D0 (en) 2004-11-26 2004-11-26 Formulation

Publications (1)

Publication Number Publication Date
GB0426142D0 true GB0426142D0 (en) 2004-12-29

Family

ID=33561496

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0426142A Ceased GB0426142D0 (en) 2004-11-26 2004-11-26 Formulation

Country Status (1)

Country Link
GB (1) GB0426142D0 (en)

Similar Documents

Publication Publication Date Title
IL189856A0 (en) New formulation
AP2006003810A0 (en) 4-Phenylamino-quinazolin-6-yl-amides
GB0423565D0 (en) Formulation
TWI370115B (en) New formulation
GB0412530D0 (en) Formulation
GB0526419D0 (en) Formulation
GB0418540D0 (en) Use
GB0414895D0 (en) Herbicidal formulation
GB0517673D0 (en) Formulation
GB0407301D0 (en) Use
GB0410015D0 (en) Use
GB0501030D0 (en) Formulation
LT1928232T (en) Solid formulation
GB0506035D0 (en) Improved formulation
GB0412878D0 (en) Use
GB0426142D0 (en) Formulation
GB0407958D0 (en) Formulation
GB0401114D0 (en) Formulation
IL179208A0 (en) Intereferon formulations
GB0408112D0 (en) Improved formulation
GB0409129D0 (en) New formulation
GB0412412D0 (en) New formulation
GB0424494D0 (en) Use
GB0507811D0 (en) Formulation
GB0510788D0 (en) Formulation

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)